An additional 3-dimensional time-of-flight MRA was carried out after the structural scan using the following parameters: TR = 20 ms; TE = 3.43 ms; FA = 18°; FOV = 640 × 580 mm; and slice thickness = 0.5 mm.
Magnetom skyra mri scanner
The MAGNETOM Skyra MRI scanner is a magnetic resonance imaging (MRI) system manufactured by Siemens. It is designed to provide high-quality imaging for clinical diagnostics. The core function of the MAGNETOM Skyra is to generate detailed images of the body's internal structures using strong magnetic fields and radio waves.
Lab products found in correlation
6 protocols using magnetom skyra mri scanner
High-Resolution Brain Imaging with MP2RAGE and TOF-MRA
An additional 3-dimensional time-of-flight MRA was carried out after the structural scan using the following parameters: TR = 20 ms; TE = 3.43 ms; FA = 18°; FOV = 640 × 580 mm; and slice thickness = 0.5 mm.
Multimodal Imaging of Gd-Au Nanocomposites
For in vivo MRI, 200 μL Gd–Au NCs or Gd-Au-NC-GPC-1 (Gd: 50 μM/kg) was intravenously injected into each COLO-357 tumor-bearing mouse (n=3). Then, MR images were obtained at different time points before (0 minute) and after (10, 30, 60, and 120 minutes) tail vein injection. MRI was performed using a 3.0 T MAGNETOM Skyra MRI scanner (Siemens) using T1-weighted sequence (Mapping, TR/TE =6.83/2.26 ms, thickness =2 mm). In addition, the relative MR intensity of the tumor region was measured and expressed as mean ± SD.
Gd-Au-NC-GPC-1 Relaxivity and MRI Evaluation
For in vitro MRI, COLO-357 and 293T cells (2×106) were treated with various concentrations of Gd-Au-NC-GPC-1 at 37°C for 2 hours. The cells were then washed 3 times with PBS and harvested by trypsinization for 3 minutes. After centrifugation at 1,000 rpm for 5 minutes, the cells were resuspended in 20 μL PBS in an Eppendorf Tube® (Axygen, CA, USA). Magnetic resonance images were acquired using a 3.0 T MAGNETOM Skyra MRI scanner (Siemens, Erlangen, Germany) using T1-weighted sequence (Mapping, repetition time/echo time [TR/TE] =6.83/2.26 ms, thickness =2 mm).
High-Resolution T1-Weighted Brain MRI
Quantifying Pancreatic Fat Deposition
Early-stage Parkinson's Disease Neuroimaging
Excluded from the study were patients with: (1) neurological abnormalities related to atypical and secondary Parkinsonism;
(2) current intake of medications known to influence autonomic functions; (3) multiple system atrophy; (4) corticobasal degeneration; (5) a history of cardiopathy or peripheral neuropathy [17] .
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!